Equities

Mangoceuticals Inc

MGRX:NAQ

Mangoceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.55
  • Today's Change0.08 / 3.24%
  • Shares traded127.79k
  • 1 Year change-69.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 20:53 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.

  • Revenue in USD (TTM)755.00k
  • Net income in USD-9.33m
  • Incorporated2021
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Mitesco Inc6.00k-4.15m3.56m3.00------593.26-0.6434-0.61210.0004-2.540.0332----2,000.00-1,094.48-246.54----0.00---33,009.50-29,214.62---0.7877---------59.12------
Syra Health Corp7.74m-4.25m3.61m78.00--1.08--0.4661-0.6471-0.64711.160.33962.20--7.9899,250.77-120.88---225.30--22.99---54.90-----5,665.830.0673---1.83---38.72------
Ethema Health Corp5.27m943.69k3.86m65.002.27--3.790.73340.00020.00020.0014-0.00220.6511--14.1781,064.167.10-37.68--------10.91-94.87---1.777.30--10.8765.34652.41--74.97--
Selectis Health Inc37.33m-6.17m4.17m574.00------0.1118-2.02-2.0212.19-1.050.8922--15.6765,027.49-14.67-3.03-25.30-3.58-----16.44-4.84---2.981.11---9.4058.97-64.93---47.72--
Biocorrx Inc26.61k-4.91m4.59m5.00------172.48-0.5186-0.51860.0028-1.060.0452--0.1606---840.98-291.68----44.6867.13-18,615.11-3,208.40---3.23-----58.31-25.0413.79------
Kindly MD Inc2.88m-2.94m5.41m23.00--1.56--1.88-0.5496-0.54960.53390.58291.113.53107.94125,017.80-113.55---152.92--93.90---102.28--5.43-6.910.054---0.488--36.34------
Medical Care Technologies Inc.0.00-1.07m5.96m0.00---------553,570.10-553,570.100.00-389.230.00-------154.94-----------------1.46---------40.06------
NewGenIvf Group Ltd0.00-690.85k6.04m----0.1422-----0.1999-0.19990.004.190.00-------1.50---1.54--------------0.0944-------237.99------
Mangoceuticals Inc755.00k-9.33m6.14m----0.3938--8.13-5.88-5.880.45846.270.092117.97-----113.83---125.71--58.60---1,235.32--0.0653-18.830.0138--8,082.22---361.07------
CompuMed Inc1.78m-151.00k6.19m8.00--47.56--3.48-0.1337-0.13371.580.09972.3836.714.83---19.92-46.77-48.38-76.7850.4257.04-8.38-25.840.9493-2.930.7744---1.73-5.7164.41---18.75--
ATI Physical Therapy Inc741.86m-79.62m7.01m6.00k------0.0095-18.57-18.57174.1717.200.7625--8.02123,643.80-5.49---6.39--16.13---7.21----0.19050.8762--9.97--73.20------
Univec Inc-100.00bn-100.00bn7.54m3.00---------------0.0113-----------50.96------17.47---198.310.0051-------74.07-64.8336.83------
Inspire Veterinary Partners Inc17.13m-19.33m7.55m156.00------0.4408-134.72-134.724.54-0.6310.816521.61246.52109,778.20-89.79---190.96--19.47---109.98--0.1311-2.741.20--69.56---206.68------
Ontrak Inc11.24m-35.68m7.72m102.00--0.5432--0.6868-10.55-10.553.023.370.5207--21.66110,186.30-123.82-54.80-228.86-73.3764.0053.50-237.77-71.95---2.270.4088---12.20-3.4439.08--99.58--
Data as of Nov 21 2024. Currency figures normalised to Mangoceuticals Inc's reporting currency: US Dollar USD

Institutional shareholders

3.98%Per cent of shares held by top holders
HolderShares% Held
Ackerman Capital Advisors LLCas of 30 Sep 202458.22k2.46%
Geode Capital Management LLCas of 30 Sep 20248.76k0.37%
Virtu Americas LLCas of 30 Jun 20246.58k0.28%
Peak6 Capital Management LLCas of 30 Sep 20245.88k0.25%
McCollum Christoferson Group LLCas of 30 Sep 20245.72k0.24%
Two Sigma Securities LLCas of 30 Sep 20242.52k0.11%
Steward Partners Investment Advisory LLCas of 30 Sep 20242.09k0.09%
XTX Markets LLCas of 30 Sep 20241.92k0.08%
Creative Planning LLCas of 30 Sep 20241.33k0.06%
CapFinancial Partners LLCas of 30 Sep 20241.14k0.05%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.